These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3391114)

  • 41. Treatment of penetrating abdominal trauma and gynecologic infections.
    Levine DP; Wilson RF
    J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
    D'Olimpio JT; Miller M; Sheridan CA; Carlisle P; Wollner DI; McKitrick JC; Wiernik PH
    J Clin Pharmacol; 1987 Sep; 27(9):673-7. PubMed ID: 3316311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
    Shlaes DM; Baughman R; Boylen CT; Chan JC; Charan NB; Cormier YC; Erickson A; Grossman R; Kirmani N; Suh B
    J Antimicrob Chemother; 1994 Oct; 34(4):565-77. PubMed ID: 7868408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
    Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
    Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic options.
    Lomaestro BM; Lesar TS
    Hosp Formul; 1988 Nov; 23(11):909. PubMed ID: 10312767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
    Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ticarcillin/clavulanate for the treatment of serious infections in hospitalized pediatric patients.
    Blumer JL
    Pediatr Infect Dis J; 1998 Dec; 17(12):1211-5. PubMed ID: 9877384
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
    Timmes JJ
    Am J Med; 1985 Nov; 79(5B):134-5. PubMed ID: 4073080
    [No Abstract]   [Full Text] [Related]  

  • 50. Penetration of ticarcillin/clavulanate into cartilage.
    Meier H; Adam D; Heilmann HD
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():101-5. PubMed ID: 2606811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of the safety and tolerance of Timentin.
    Croydon EA; Hermoso C
    J Antimicrob Chemother; 1986 May; 17 Suppl C():233-40. PubMed ID: 3722045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of endomyometritis.
    Yonekura ML
    J Reprod Med; 1988 Jun; 33(6 Suppl):579-83. PubMed ID: 3260948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clavulanate-potentiated ticarcillin: high-performance liquid chromatographic assays for clavulanic acid and ticarcillin isomers in serum and urine.
    Watson ID
    J Chromatogr; 1985 Feb; 337(2):301-9. PubMed ID: 3988860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of ticarcillin/clavulanate in severely burned patients.
    Adam D; Zellner PR; Koeppe P; Wesch R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():121-9. PubMed ID: 2606814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR; Aronoff SC; Johenning S; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid penetration after single or multiple dosage with ticarcillin/clavulanate.
    Franz P; von Rosen F; Garner C; Swozil U; Schmiedek P; Einhäupl K; Adam D
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():107-10. PubMed ID: 2606812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units.
    Schwigon CD; Hulla FW; Schulze B; Maslak A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():115-22. PubMed ID: 3636326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic-associated maculopapular reaction.
    Wright LJ; Tomlinson N; Dy L
    Ann Pharmacother; 2002 Dec; 36(12):1969. PubMed ID: 12494953
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative aminoglycoside inactivation by potassium clavulanate.
    Courcol RJ; Martin GR
    J Antimicrob Chemother; 1986 May; 17(5):682-4. PubMed ID: 3722038
    [No Abstract]   [Full Text] [Related]  

  • 60. [Spektramox and liver damage].
    Lakartidningen; 1996 Feb; 93(6):490. PubMed ID: 8637331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.